161 related articles for article (PubMed ID: 30199752)
1. hCD46 receptor is not required for measles vaccine Schwarz strain replication in vivo: Type-I IFN is the species barrier in mice.
Mura M; Ruffié C; Billon-Denis E; Combredet C; Tournier JN; Tangy F
Virology; 2018 Nov; 524():151-159. PubMed ID: 30199752
[TBL] [Abstract][Full Text] [Related]
2. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.
Combredet C; Labrousse V; Mollet L; Lorin C; Delebecque F; Hurtrel B; McClure H; Feinberg MB; Brahic M; Tangy F
J Virol; 2003 Nov; 77(21):11546-54. PubMed ID: 14557640
[TBL] [Abstract][Full Text] [Related]
3. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
Schneider-Schaulies J; Schnorr JJ; Brinckmann U; Dunster LM; Baczko K; Liebert UG; Schneider-Schaulies S; ter Meulen V
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3943-7. PubMed ID: 7732009
[TBL] [Abstract][Full Text] [Related]
4. Wild type measles virus attenuation independent of type I IFN.
Druelle J; Sellin CI; Waku-Kouomou D; Horvat B; Wild FT
Virol J; 2008 Feb; 5():22. PubMed ID: 18241351
[TBL] [Abstract][Full Text] [Related]
5. Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques.
Takeuchi K; Nagata N; Kato SI; Ami Y; Suzaki Y; Suzuki T; Sato Y; Tsunetsugu-Yokota Y; Mori K; Van Nguyen N; Kimura H; Nagata K
J Virol; 2012 Mar; 86(6):3027-37. PubMed ID: 22238320
[TBL] [Abstract][Full Text] [Related]
6. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration.
Condack C; Grivel JC; Devaux P; Margolis L; Cattaneo R
J Infect Dis; 2007 Aug; 196(4):541-9. PubMed ID: 17624839
[TBL] [Abstract][Full Text] [Related]
7. An immune competent mouse model for the characterization of recombinant measles vaccines.
Marty RR; Knuchel MC; Morin TN; Naim HY
Hum Vaccin Immunother; 2015; 11(1):83-90. PubMed ID: 25483519
[TBL] [Abstract][Full Text] [Related]
8. Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.
Baldo A; Galanis E; Tangy F; Herman P
Hum Vaccin Immunother; 2016 May; 12(5):1102-16. PubMed ID: 26631840
[TBL] [Abstract][Full Text] [Related]
9. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
10. Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level.
Escoffier C; Gerlier D
J Virol; 1999 Jun; 73(6):5220-4. PubMed ID: 10233992
[TBL] [Abstract][Full Text] [Related]
11. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
12. Attenuated measles virus as a vaccine vector.
Zuniga A; Wang Z; Liniger M; Hangartner L; Caballero M; Pavlovic J; Wild P; Viret JF; Glueck R; Billeter MA; Naim HY
Vaccine; 2007 Apr; 25(16):2974-83. PubMed ID: 17303293
[TBL] [Abstract][Full Text] [Related]
13. Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).
Pfeuffer J; Püschel K; Meulen Vt; Schneider-Schaulies J; Niewiesk S
J Virol; 2003 Jan; 77(1):150-8. PubMed ID: 12477820
[TBL] [Abstract][Full Text] [Related]
14. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus.
Shingai M; Ebihara T; Begum NA; Kato A; Honma T; Matsumoto K; Saito H; Ogura H; Matsumoto M; Seya T
J Immunol; 2007 Nov; 179(9):6123-33. PubMed ID: 17947687
[TBL] [Abstract][Full Text] [Related]
15. Biological characterization of clones derived from the Edmonston strain of measles virus in comparison with Schwarz and CAM-70 vaccine strains.
Borges MB; Mann GF; Freire Mda S
Mem Inst Oswaldo Cruz; 1996; 91(4):507-13. PubMed ID: 9070412
[TBL] [Abstract][Full Text] [Related]
16. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
17. Noncanonical Transmission of a Measles Virus Vaccine Strain from Neurons to Astrocytes.
Poelaert KCK; Williams RM; Matullo CM; Rall GF
mBio; 2021 Mar; 12(2):. PubMed ID: 33758092
[TBL] [Abstract][Full Text] [Related]
18. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
Rennick LJ; de Vries RD; Carsillo TJ; Lemon K; van Amerongen G; Ludlow M; Nguyen DT; Yüksel S; Verburgh RJ; Haddock P; McQuaid S; Duprex WP; de Swart RL
J Virol; 2015 Feb; 89(4):2192-200. PubMed ID: 25473055
[TBL] [Abstract][Full Text] [Related]
19. Measles virus and CD46.
Kemper C; Atkinson JP
Curr Top Microbiol Immunol; 2009; 329():31-57. PubMed ID: 19198561
[TBL] [Abstract][Full Text] [Related]
20. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
